(19)

(11)

EP 4 562 132 A2

(12)

(88) Date of publication A3: 04.04.2024 (43) Date of publication: 04.06.2025 Bulletin 2025/23 (21) Application number: 23847416.7 (22) Date of filing: 28.07.2023

(51) International Patent Classification (IPC):  C12N 5/0783(2010.01) C12N 15/62(2006.01) A61K 35/17(2025.01) C12N 5/10(2006.01) (52) Cooperative Patent Classification (CPC): C07K 14/7051; A61P 35/00; A61K 38/2013; A61K 38/2086; C12N 2510/00; C12N 2501/515; C12N 5/0636; A61K 40/35; A61K 40/4232; A61K 40/31; A61K 40/11   C-Sets: A61K 38/2013, A61K 2300/00; A61K 38/2086, A61K 2300/00; (86) International application number: PCT/US2023/029047 (87) International publication number: WO 2024/026127 (01.02.2024 Gazette 2024/05)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 29.07.2022 US 202263393787 P (71) Applicant: Adicet Therapeutics, Inc. Redwood City, CA 94065 (US)

(72) Inventors: AFTAB, Blake Redwood City, CA 94065 (US) BHAT, Arun Redwood City, CA 94065 (US) NISHIMOTO, Kevin Redwood City, CA 94065 (US) TEAGUE, Alexander Redwood City, CA 94065 (US) SPELTZ, Elizabeth Redwood City, CA 94065 (US) LAMTURE, Gauri Redwood City, CA 94065 (US) DING, Beibei Redwood City, CA 94065 (US) RAMADOSS, Nitya Redwood City, CA 94065 (US) (74) Representative: Mathys & Squire  The Shard 32 London Bridge Street London SE1 9SG London SE1 9SG (GB)